InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by BERNS PAUL L, Director. Director active across 2 companies, notably Jazz Pharmaceuticals plc. Cumulatively, 4 disclosures have been published. Total volume traded: €377k. The latest transaction was filed on 5 August 2021 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
627,000 shares
Common Stock
SEC:0000899243-21-049123:0·
627,000 shares
Common Stock
SEC:0000899243-21-049123·
€188,6661,450 shares@ €130.11460.0013% mcap100.0% of flow
Ordinary Shares
SEC:0001765581-21-000096·
€188,6661,450 shares@ €130.11460.0013% mcap50.0% of flow
Ordinary Shares
SEC:0001765581-21-000096:0·
4 of 4 declarations
About BERNS PAUL L
Paul L. Berns is a Board Member of Jazz Pharmaceuticals plc and EQRx, Inc. In this role, he participates in overseeing the activities of these companies and shaping their strategies. Berns brings significant expertise in the pharmaceutical sector, allowing him to contribute effectively to board discussions. His commitment to innovation and continuous improvement is essential for the development of these companies.
